Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Archana Gopalakrishnan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|June 22, 2016
Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the questionArchana Gopalakrishnan, Padmini Salgame
F1000Prime Reports|May 1, 2015
Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad copJillian Dietzold, Archana Gopalakrishnan, Padmini Salgame
Cellular Immunology|January 11, 2016
Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9Archana Gopalakrishnan, Jillian Dietzold, Padmini Salgame
Sultan Qaboos University Medical Journal|July 11, 2017
Use of Cone-Beam Computed Tomography in the Diagnosis and Treatment of an Unusual Canine AbnormalityArchana Gopalakrishnan, K Unnikrishna, Anita Balan, et al.
Infection and Immunity|December 19, 2018
Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 ProductionArchana Gopalakrishnan, Jillian Dietzold, Sheetal Verma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2016
Divergent Functions of TLR2 on Hematopoietic and Nonhematopoietic Cells during Chronic Mycobacterium tuberculosis InfectionJill Konowich, Archana Gopalakrishnan, Jillian Dietzold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2022
E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling InsufficiencyArchana Gopalakrishnan, Katharina Richard, Rezwanul Wahid, et al.
European Urology Oncology|June 16, 2026
Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE TrialsAlexander Light, Max Peters, Archana Gopalakrishnan, et al.
Frontiers in Immunology|September 2, 2022
Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiationArchana Gopalakrishnan, John Joseph, Kari Ann Shirey, et al.
Vaccine|May 12, 2020
Dissociation of TRIF bias and adjuvanticityKatharina Richard, Darren J Perkins, Erin M Harberts, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|June 22, 2016
Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the questionArchana Gopalakrishnan, Padmini Salgame
F1000Prime Reports|May 1, 2015
Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad copJillian Dietzold, Archana Gopalakrishnan, Padmini Salgame
Cellular Immunology|January 11, 2016
Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9Archana Gopalakrishnan, Jillian Dietzold, Padmini Salgame
Sultan Qaboos University Medical Journal|July 11, 2017
Use of Cone-Beam Computed Tomography in the Diagnosis and Treatment of an Unusual Canine AbnormalityArchana Gopalakrishnan, K Unnikrishna, Anita Balan, et al.
Infection and Immunity|December 19, 2018
Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 ProductionArchana Gopalakrishnan, Jillian Dietzold, Sheetal Verma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2016
Divergent Functions of TLR2 on Hematopoietic and Nonhematopoietic Cells during Chronic Mycobacterium tuberculosis InfectionJill Konowich, Archana Gopalakrishnan, Jillian Dietzold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2022
E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling InsufficiencyArchana Gopalakrishnan, Katharina Richard, Rezwanul Wahid, et al.
European Urology Oncology|June 16, 2026
Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE TrialsAlexander Light, Max Peters, Archana Gopalakrishnan, et al.
Frontiers in Immunology|September 2, 2022
Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiationArchana Gopalakrishnan, John Joseph, Kari Ann Shirey, et al.
Vaccine|May 12, 2020
Dissociation of TRIF bias and adjuvanticityKatharina Richard, Darren J Perkins, Erin M Harberts, et al.
Pageof 2